Fig. 2
From: Biodistribution of arctigenin-loaded nanoparticles designed for multimodal imaging
BF NP and AF NP bioimaging in 4 dpf zebrafish in vivo. A The untreated control group is represented in a; b and c represent BF NPs treated for 1 and 2 h, respectively; d, e and f represent AF NPs treated for 1, 2 and 3 h, respectively. B Sections from the treated groups of BF NPs (a–c) and the treated groups of AF NPs (d–f) at 2 h post treatment are shown. The scale bar indicates 500 µm